| Aug 5 |
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
|
| Aug 1 |
Recursion Pharmaceuticals: AI-Driven 'TechBio' With Upcoming Catalysts
|
| Aug 1 |
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
| Jul 31 |
99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks
|
| Jul 29 |
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: Here's Why
|
| Jul 27 |
Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
|
| Jul 26 |
Wall Street Analysts Predict a 43.73% Upside in Recursion Pharmaceuticals (RXRX): Here's What You Should Know
|
| Jul 18 |
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
|
| Jul 16 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
| Jul 14 |
Is Recursion Pharmaceuticals Stock a Buy?
|
